Rhonda E. Ries
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Hematology 93
- Acute Myeloid Leukemia Research 93
- Chronic Myeloid Leukemia Treatments 8
-
- Protein Degradation and Inhibitors 32
- Histone Deacetylase Inhibitors Research 10
- Epigenetics and DNA Methylation 9
- Co-authors
- Soheil Meshinchi (95 shared papers)Todd A. Alonzo (64 shared papers)Alan S. Gamis (49 shared papers)Richard Aplenc (36 shared papers)Robert B. Gerbing (34 shared papers)Betsy Hirsch (22 shared papers)Susana C. Raimondi (20 shared papers)Michael R. Loken (16 shared papers)
- Journals
- Blood (65 papers)Journal of Clinical Oncology (7 papers)Blood Advances (5 papers)Clinical Cancer Research (4 papers)Cancer Research (3 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Rhonda E. Ries
99 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 63
- Hematology 636
- Cancer Research 160
- Genetics 113
- Molecular Biology 553
- Oncology 174
Countries citing papers authored by Rhonda E. Ries
This map shows the geographic impact of Rhonda E. Ries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda E. Ries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda E. Ries more than expected).
Fields of papers citing papers by Rhonda E. Ries
This network shows the impact of papers produced by Rhonda E. Ries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda E. Ries. The network helps show where Rhonda E. Ries may publish in the future.
Co-authors
The 25 scholars most cited alongside Rhonda E. Ries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 105 | |
| 2 | 2017 | 104 | |
| 3 | 2019 | 80 | |
| 4 | 2005 | 70 | |
| 5 | 2021 | 59 | |
| 6 | 2014 | 53 | |
| 7 | 2016 | 42 | |
| 8 | 2015 | 41 | |
| 9 | 2019 | 39 | |
| 10 | 2023 | 36 | |
| 11 | 2021 | 22 | |
| 12 | 2018 | 22 | |
| 13 | 2015 | 21 | |
| 14 | 2017 | 20 | |
| 15 | 2023 | 17 | |
| 16 | 2015 | 15 | |
| 17 | 2017 | 15 | |
| 18 | 2014 | 15 | |
| 19 | 2019 | 13 | |
| 20 | 2019 | 11 |
About Rhonda E. Ries
Rhonda E. Ries is a scholar working on Hematology, Molecular Biology, Cancer Research, Genetics and Public Health, Environmental and Occupational Health, having authored 111 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (93 papers), Protein Degradation and Inhibitors (32 papers), Cancer Genomics and Diagnostics (25 papers), Acute Lymphoblastic Leukemia research (12 papers), Histone Deacetylase Inhibitors Research (10 papers), Epigenetics and DNA Methylation (9 papers), CAR-T cell therapy research (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Hematology (636 citations), Cancer Research (160 citations), Genetics (113 citations), Molecular Biology (553 citations) and Oncology (174 citations). Rhonda E. Ries has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Soheil Meshinchi, Todd A. Alonzo, Alan S. Gamis, Richard Aplenc, Robert B. Gerbing, Betsy Hirsch, Susana C. Raimondi, Michael R. Loken, Roland B. Walter and E. Anders Kolb. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.